Individualized ANH for Non-cardiac Surgery

Recruiting now · Not applicable

Conditions studied: Transfusion Related Complication, Hemodilution

In brief

In this trial, we proposed an individualized acute normovolemic hemodilution (ANH), and conduct a randomized controlled trial to testify the effect of individualized ANH on red cells requirement for non-cardiac surgeries with anticipating major blood loss in adults.

Key facts

Study ID

NCT06399536

Run by

West China Hospital

People needed

40

Starts

2024-06-01

Expected to finish

2026-12-31

Last updated by the study team

2024-12-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing elective non-cardiac surgery with an anticipated red blood cells transfusion >8 units (or 1600ml)
• Aged 18\~75 years
• Preoperative Hb level > 120g/L for men and > 110g/L for women.

You may not qualify if…

• Refusal of blood transfusion
• Cardiopulmonary insufficiency
• Cerebrovascular disease
• Renal impairment
• Hemoglobinopathies or blood system diseases
• Other situations not suitable for inclusion in clinical trial.

Where it is running

• West China Hospital of Sichuan University — Chengdu, Sichuan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.